This sequence was reported to inhibit the primary target of HIV infection, binding to the envelope glycoprotein gp120 by aptameric recognition only when conjugated at the 5′-end with a lipophilic group (Figure 1b, R-95288; IC50 = 0.37 μM). The gene discussed is ERVW-1; the disease is HIV infectious disease.